Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 10Breast 9Gastrointestinal 5Thoracic 4Other hematologic neoplasm 4Tumor-Agnostic 3Sarcoma 3Lymphoid 3Genitourinary 2Plasma cell 1Other solid neoplasm 1Myeloid 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Medulloblastoma 1Basal Cell Nevus Syndrome 1

Interventions

Ipilimumab 123pembrolizumab 101Nivolumab 100aldesleukin 89Cyclophosphamide 85fludarabine phosphate 64Interleukin-2 58Dacarbazine 573-ingenyl angelate 42Vemurafenib 39Temozolomide 39Imiquimod 39trametinib 37sargramostim 37Peripheral Blood Stem Cell Transplantation 36incomplete Freund's adjuvant 35dabrafenib 32fludarabine 31Radiotherapy 31Aminolevulinic Acid 30Bevacizumab 29Carboplatin 28Whole-Body Irradiation 25Photochemotherapy 25Paclitaxel 25Filgrastim 25Biopsy 25Interferon-alpha 24Cisplatin 23Sorafenib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mental Status and Dementia Tests × Dermatologic × Clear all
NCT02017964 2023-01-09

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Children's Oncology Group

Phase 2 Completed
26 enrolled 14 charts
CNSDermatologic

Basal Cell Nevus Syndrome, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡